P07 A Phase 3 randomized, double-blind, comparator-controlled study to evaluate safety, tolerability and immunogenicity of V114 pneumococcal vaccine in haematopoietic cell transplant recipients (PNEU-STEM)

BACKGROUND: Allogeneic haematopoietic cell transplant (allo-HCT) represents a definitive therapy for a variety of haematological diseases. Immunosuppressive therapy following allo-HCT and graft-versus-host disease (GVHD) render the patient susceptible to infectious complications, including invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilck, Marissa, Cornely, Oliver A, Ljungman, Per, Cordonnier, Catherine, Velez, Juan Diego, Dagan, Ron, Richmond, Peter, Chen, Qiuxu, Daus, Caroline, Geddie, Kateasha, Sterling, Tina, Shekar, Tulin, Musey, Luwy, Buchwald, Ulrike K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848846/
http://dx.doi.org/10.1093/jacamr/dlac133.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848846/
http://dx.doi.org/10.1093/jacamr/dlac133.011

Ejemplares similares